Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)
Authors:
- 22 February 2020
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (4) , 640-645
Abstract
Marginal zone lymphomas (MZLs) are rare and indolent subtypes of non-Hodgkin lymphomas, and their clinical behaviours are heterogeneous. The aim of this study was to evaluate the clinical and prognostic characteristics of MZL. In this multicentre retrospective study, we analyzed demographical, clinical and prognostic features of 64 MZL patients. The median age was 54.0 and 78.1% of the patients had extra-nodal disease at presentation. Most of the patients were treated with chemotherapy. The 5 years and 10 years overall survival (OS) rates were 74.5% and 62.1%, respectively. The analysis of factors associated with OS showed that ECOG performance score was an important prognostic factor, with 133.0 months (95% CI 49.3–216.5) versus 18.0 months (95% CI 12.1–23.7) for ECOG 0–1 and 2–3, respectively (p = 0.011). Prognosis of MZL is favorable and ECOG performance score was found associated with OS. Further detailed studies with large patient numbers are needed to clarify the clinical features and treatment management of MZLs.Keywords
This publication has 19 references indexed in Scilit:
- Dual institution experience of extranodal marginal zone lymphoma reveals excellent long‐term outcomesBritish Journal of Haematology, 2016
- Management of the Marginal Zone Lymphomas2015
- Survival of patients with marginal zone lymphomaCancer, 2012
- Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphomaCancer, 2012
- Marginal zone lymphomasCancer, 2010
- Immunoarchitectural Patterns in Nodal Marginal Zone B-Cell LymphomaAmerican Journal of Clinical Pathology, 2009
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001Blood, 2006
- Clinical Presentation and Management of Marginal Zone LymphomasHematology-American Society Hematology Education Program, 2005
- Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profilesCancer, 2003
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003